BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 25725418)

  • 1. Manganoporphyrins and ascorbate enhance gemcitabine cytotoxicity in pancreatic cancer.
    Cieslak JA; Strother RK; Rawal M; Du J; Doskey CM; Schroeder SR; Button A; Wagner BA; Buettner GR; Cullen JJ
    Free Radic Biol Med; 2015 Jun; 83():227-37. PubMed ID: 25725418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manganoporphyrins increase ascorbate-induced cytotoxicity by enhancing H2O2 generation.
    Rawal M; Schroeder SR; Wagner BA; Cushing CM; Welsh JL; Button AM; Du J; Sibenaller ZA; Buettner GR; Cullen JJ
    Cancer Res; 2013 Aug; 73(16):5232-41. PubMed ID: 23764544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer therapeutic potential of Mn porphyrin/ascorbate system.
    Tovmasyan A; Sampaio RS; Boss MK; Bueno-Janice JC; Bader BH; Thomas M; Reboucas JS; Orr M; Chandler JD; Go YM; Jones DP; Venkatraman TN; Haberle S; Kyui N; Lascola CD; Dewhirst MW; Spasojevic I; Benov L; Batinic-Haberle I
    Free Radic Biol Med; 2015 Dec; 89():1231-47. PubMed ID: 26496207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Pharmacological Ascorbate Oxidation Radiosensitizes Pancreatic Cancer.
    Alexander MS; O'Leary BR; Wilkes JG; Gibson AR; Wagner BA; Du J; Sarsour E; Hwang RF; Buettner GR; Cullen JJ
    Radiat Res; 2019 Jan; 191(1):43-51. PubMed ID: 30376411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic Ascorbate Reduces Radiation-Induced Normal Tissue Toxicity and Enhances Tumor Radiosensitization in Pancreatic Cancer.
    Alexander MS; Wilkes JG; Schroeder SR; Buettner GR; Wagner BA; Du J; Gibson-Corley K; O'Leary BR; Spitz DR; Buatti JM; Berg DJ; Bodeker KL; Vollstedt S; Brown HA; Allen BG; Cullen JJ
    Cancer Res; 2018 Dec; 78(24):6838-6851. PubMed ID: 30254147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual Oxidase-Induced Sustained Generation of Hydrogen Peroxide Contributes to Pharmacologic Ascorbate-Induced Cytotoxicity.
    Gibson AR; O'Leary BR; Du J; Sarsour EH; Kalen AL; Wagner BA; Stolwijk JM; Falls-Hubert KC; Alexander MS; Carroll RS; Spitz DR; Buettner GR; Goswami PC; Cullen JJ
    Cancer Res; 2020 Apr; 80(7):1401-1413. PubMed ID: 32041838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor cells have decreased ability to metabolize H
    Doskey CM; Buranasudja V; Wagner BA; Wilkes JG; Du J; Cullen JJ; Buettner GR
    Redox Biol; 2016 Dec; 10():274-284. PubMed ID: 27833040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Pancreatic Cancer with Pharmacological Ascorbate.
    Cieslak JA; Cullen JJ
    Curr Pharm Biotechnol; 2015; 16(9):759-70. PubMed ID: 26201606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic Ascorbate Primes Pancreatic Cancer Cells for Death by Rewiring Cellular Energetics and Inducing DNA Damage.
    Buranasudja V; Doskey CM; Gibson AR; Wagner BA; Du J; Gordon DJ; Koppenhafer SL; Cullen JJ; Buettner GR
    Mol Cancer Res; 2019 Oct; 17(10):2102-2114. PubMed ID: 31337671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological ascorbate induces sustained mitochondrial dysfunction.
    Carroll RS; Du J; O'Leary BR; Steers G; Goswami PC; Buettner GR; Cullen JJ
    Free Radic Biol Med; 2023 Aug; 204():108-117. PubMed ID: 37137343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic ascorbate (P-AscH
    Wilkes JG; O'Leary BR; Du J; Klinger AR; Sibenaller ZA; Doskey CM; Gibson-Corley KN; Alexander MS; Tsai S; Buettner GR; Cullen JJ
    Clin Exp Metastasis; 2018 Feb; 35(1-2):37-51. PubMed ID: 29396728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manipulation of Redox Metabolism Using Pharmacologic Ascorbate Opens a Therapeutic Window for Radio-Sensitization by ATM Inhibitors in Colorectal Cancer.
    Callaghan CM; Abukhiran IM; Masaadeh A; Van Rheeden RV; Kalen AL; Rodman SN; Petronek MS; Mapuskar KA; George BN; Coleman MC; Goswami PC; Allen BG; Spitz DR; Caster JM
    Int J Radiat Oncol Biol Phys; 2023 Mar; 115(4):933-944. PubMed ID: 36228747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer.
    Du J; Martin SM; Levine M; Wagner BA; Buettner GR; Wang SH; Taghiyev AF; Du C; Knudson CM; Cullen JJ
    Clin Cancer Res; 2010 Jan; 16(2):509-20. PubMed ID: 20068072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with gemcitabine and TRA-8 anti-death receptor-5 mAb reduces pancreatic adenocarcinoma cell viability in vitro and growth in vivo.
    DeRosier LC; Huang ZQ; Sellers JC; Buchsbaum DJ; Vickers SM
    J Gastrointest Surg; 2006 Nov; 10(9):1291-300; discussion 1300. PubMed ID: 17114015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer.
    Espey MG; Chen P; Chalmers B; Drisko J; Sun AY; Levine M; Chen Q
    Free Radic Biol Med; 2011 Jun; 50(11):1610-9. PubMed ID: 21402145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metalloporphyrin synergizes with ascorbic acid to inhibit cancer cell growth through fenton chemistry.
    Tian J; Peehl DM; Knox SJ
    Cancer Biother Radiopharm; 2010 Aug; 25(4):439-48. PubMed ID: 20735206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced effect of gemcitabine by emodin against pancreatic cancer in vivo via cytochrome C-regulated apoptosis.
    Chen H; Wei W; Guo Y; Liu A; Tong H; Wang Z; Tan W; Liu J; Lin S
    Oncol Rep; 2011 May; 25(5):1253-61. PubMed ID: 21305255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological ascorbate inhibits pancreatic cancer metastases via a peroxide-mediated mechanism.
    O'Leary BR; Alexander MS; Du J; Moose DL; Henry MD; Cullen JJ
    Sci Rep; 2020 Oct; 10(1):17649. PubMed ID: 33077776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological Ascorbate Radiosensitizes Pancreatic Cancer.
    Du J; Cieslak JA; Welsh JL; Sibenaller ZA; Allen BG; Wagner BA; Kalen AL; Doskey CM; Strother RK; Button AM; Mott SL; Smith B; Tsai S; Mezhir J; Goswami PC; Spitz DR; Buettner GR; Cullen JJ
    Cancer Res; 2015 Aug; 75(16):3314-26. PubMed ID: 26081808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting signal transducer and activator of transcription-3 increases response to gemcitabine and delays progression of pancreatic cancer.
    Venkatasubbarao K; Peterson L; Zhao S; Hill P; Cao L; Zhou Q; Nawrocki ST; Freeman JW
    Mol Cancer; 2013 Sep; 12(1):104. PubMed ID: 24025152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.